Atrogin-1 is a conserved ubiquitin E3 ligase that is central to the early stages of skeletal and 27 cardiac muscle wasting and degradation following starvation and inflammatory diseases. The 28 control of protein turnover is different between endothermic and ectothermic animals 29 reflecting the body energy requirements. Here we have characterised the promoter of the 30 atrogin-1 gene in a phylogenetically diverse group of vertebrates and show conserved FOXO 31 elements are present in all species examined. We have examined the gene expression 32 responses in primary muscle cell culture to key immune modulators (IL-1β, interferon type 1 33 and interferon γ) and to the anabolic hormone insulin like growth factor (IGF-1). We show 34 that the IL-1β and interferon type 1 increased atrogin-1 mRNA expression whereas IGF-1 35 suppressed atrogin-1 expression. The proximal promoter of salmon atrogin-1 was used to 36 transfect primary muscle cell cultures and we found all three cytokines increased promoter 37 activity whereas there was a decrease caused by IGF-1 exposure. We hypothesise that the 38 main drivers for atrogin-1 expression are via the conserved FOXO site, but other transcription 39 binding sites such as NFκΒ, STAT and IRFs may also be involved in a synergistic manner 40 following immune stimulation when free amino acids need to be released for muscle protein 41 reserves. 42 2 Introduction 43
However, the regulation of this response has not been examined in lower vertebrates, as these 81 animals will have different energy requirements than endothermic mammals. 82
In this paper we have characterised the proximal promoter of the Atlantic salmon 83 (Salmo salar) atrogin-1 gene and identified evolutionary conserved transcription factor 84 binding sites, we have also examined the promoter activity in primary muscle cell culture. 85
Transfected primary myocytes with an atrogin-1 luciferase reporter construct were stimulated 86 with salmonid recombinant cytokines IFN type 1, IFN-γ and IL-1β, in parallel we also used 87 recombinant salmon IGF-1 as an anabolic hormone. We show that the immune regulating 88 cytokines increased atrogin-1 activity whereas IGF-1 has a suppressive effect on the atrogin-1 89 gene. 90
91

Materials and methods 92
Sequence identification, analysis and generation of reporter plasmid 93
The proximal promoter of the Atlantic salmon atrogin-1 gene was identified following a 94
BlastN search of the Atlantic salmon genome using the salmon atrogin-1 cDNA sequence 95 (accession number, NM_001185027.1) as query. A contig sequence (accession number, 96 AGKD00000000.3, contig AGKD03111157.1) was identified that had 100% identity of the 97 query sequence. This sequence was analysed for the putative promoter and the transcription 98 start sites. DNA repeats present in the sequence were analysed by DNA Repeats Finder 99 (Benson, 1999) (http://tandem.bu.edu/trf/trf.html). The DNA regulatory sequence motifs 100 were predicted by the Genomatix Software tools "common TFs" and "Matbase TFs" 101 (Cartharius et al., 2005 PMID: 15860560) . For comparison to other species the flanking 102 regions were obtained from species with published genomes from Ensemble. 103
Salmon genomic DNA was extracted from muscle tissue using a genomic extraction 104 kit (Promega). To clone the proximal promoter, primers were designed that included 105 restriction enzyme sites to allow for directional cloning (Table 1) . PCR was performed using product was separated on a 2% agarose gel, stained with web green (Genetics) and analysed 111 in a UV image analysis system. PCR products were digested with the appropriate restriction 112 enzymes, Kpn I and Xho I (Promega), for 1 h at 37 ºC, following the manufacturer's 113 instructions, and purified using a PCR Purification Kit (Invitrogen). The purified PCR 114 products were ligated into pre-digested pGL4.10 luciferase reporter vector (Promega), using 115 T4 DNA ligase (Promega) at 4 ºC overnight, the ligation reaction was used to transformation 116 of E. coli TAM1 cells (Active Motif, Belgium) following the manufacturer's instructions. 117
The plasmid insert sequence was confirmed by PCR using pGL4 RV primer 3 (Promega). 118
Plasmids were purified from overnight bacterial cultures using an Endotoxin Free Plasmid 119
Maxi Kit (Qiagen). Plasmid concentrations were determined by spectrophotometry using a 120 repeat sequences, one with 25 copies of CATAACACATCACATCATAACACAT followed 225 by 103 copies of GA and then repeating GAAGTGTACATTTGACTGG to the end of the 226 sequence. Therefore, in this study we used non repeating 590 bp region of the 5' flanking 227 DNA as proximal promoter region for further analysis. The atrogin-1 gene proximal promoter 228 region was analysed for transcription factor binding sites using Genomatix Software. This 229 revealed a number of highly conserved sites that may be involved in regulation of gene 230 transcription (Fig.1) . The promoter region contained several well conserved transcription 231 factor binding sites, these included a highly conserved FOXO site that was located 51 bp 232 upstream of the predicted transcription start site, other conserved sites include a TATA box at 233 -23 bp and several forkhead binding sites as represented by FOXP1 (3 elements), FOXJ and 234 FHXB. We also found several TF binding sites associated with inflammatory and interferon 235 responses including several STAT binding sites which can be defined as gamma interferon 236 activated sites (GAS) and interferon regulatory factor binding elements (IRF). Also present 237 was a conserved NFκB site. When the promoter sequence and predicted transcription factor 238 binding sites were compared across other vertebrate atrogin-1 proximal promoters we find a 239 highly conserved location of the FOXO site in all species examined (Fig 2a.) . In all the fish 240 and the amphibian the conserved sequence is GATAACA, with the mammals having a single 241 bases change at the 5' base, which is recognised as being a FOXO element. In all the species 242 there is also a CEBP site located at -122 bp from the transcription start site (TSS) in salmon, 243 in all species these two sites are 10-20bp apart and in the same orientation. All the species 244 examined have varying numbers of forkhead binding sites, STAT elements and most have at 245 least one IRF site, the position of these is conserved between Atlantic salmon and rainbow 246 trout, but there is no detectable conservation of location between the more distantly related 247
species. 248
Atrogin-1 mRNA responses to cytokine and IGF-1 stimulation 249 Our next step was to examine the gene expression response of the salmon primary muscle 250 cells to the recombinant proteins. The initial part of this was to validate the response of genes 251 known to respond to the cytokines or IGF-1 in other cell types as confirmation of 252 responsiveness in our primary muscle cell system. For saIGF-1 activity, expression of IGF-1 253 mRNA was examined as a negative feedback, we found that concentrations of 50 and 200 ng 254 of the recombinant protein significantly reduced IGF-1 mRNA expression. For activity of IL-255 1β we chose to use IGF binding protein 6 (IGFBP6) previously shown to be highly 256 responsive to IL-1β in salmon muscle cells (Pooley et al 2013) , this gene was highly 257 increased in expression in response to the IL-1β. For the interferons, the classically 258 responsive genes Mx and chemokine CXCL11_L1 were used to assess response to IFN-1 and 259 IFN-γ respectively (Fig. 3) showing large increases in expression 24 h following stimulation. 260
Following confirmation of the response in the muscle cells to our recombinant 261 proteins we examined the expression of the atrogin-1 mRNA following the same stimulation. 262
Atrogin-1 mRNA expression was significantly decreased following 6 h saIGF-1 exposure but 263 not 24 h (data not shown), whereas both IL-1β and IFN-1 resulted in an increase in atrogin-1 264 gene expression following 24 h, however we did not detect a significant change in expression 265 in response to IFN-γ (Fig. 4) . 266 267
Analysis of atrogin-1 gene promoter in primary muscle cell culture 268
To initiate the transfection studies, preliminary experiments were performed with a control 269 plasmid to determine the transfection efficiency as there are few protocols for transfection 270 into primary myocytes. Our protocol showed we obtained approximately 20% transfection 271 efficiency when the pturboGFP plasmid was used (Fig. S3) . 272
To examine the luciferase activity of the atrogin-1 promoter construct transfected 273 cells were cultured for under similar regime as for gene expression studies. All three 274 cytokines induce a significant increase in luciferease activity driven by the atrogin-1 275 promoter, however the response is only significant at the higher recombinant protein 276 concentrations (200 ng/ml for IL-1β and 80 ng/ml for both interferons). The saIGF-1 277 resulted in a small decrease in activity compared to the unstimulated control (Fig. 5) . 278
279
Discussion 280
The Atlantic salmon atrogin-1 promoter was used to examine the regulation of this key gene 281 that can be regarded as a marker for catabolic activity in muscle tissue. The proximal 282 promoter was identified from the Atlantic salmon genome and used as a starting point to 283 generate a luciferase reporter plasmid. The plasmid was used for transfections using primary 284 muscle cell cultures, following this the cells were exposed to three key cytokines, IL-1β, 285 IFN-1, and IFN-γ and, in addition the cells were stimulated with IGF-1 which is a well 286 characterised anabolic hormone. We showed that the three cytokines increased luciferase 287 activity following 24 h exposure whereas the IGF-1 caused a marginal decrease in reporter 288 assay compared to control. Gene expression of atrogin-1 was increased by IL-1β and IFN-1, SaIGF-1 protein (300 ng) was separated on a SDS-PAGE gel under denaturing conditions. 597 598 Figure S2 : 599 Table 1 : Primers used for Atlantic salmon atrogin-1 expression and promoter construction.
